Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice

Stroke

Volumn 29, Issue 7, 1998, Pages 1411-1416

  Christenson, Stuart D ^a   Lake, Kristy D ^a   Ooboshi, Hiroaki ^a   Faraci, Frank M ^a   Davidson, Beverly L ^a   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Adenovirus; Cerebral arteries; Gene transfer; Mice; Promoter regions (genetics)

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CHEMOLUMINESCENCE; CISTERNA MAGNA; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE TRANSFER; LEPTOMENINX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; ROUS SARCOMA ONCOVIRUS;

EID: 0031837206     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.7.1411     Document Type: Article

References (38)

1. Nabel EG, Nabel GJ. Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol. 1994;56:741-761.
2. Trapnell BC. Adenovirus vectors for gene transfer. Adv Drug Deliv Rev. 1993;12:185-199.
3. Schneider MD, French BA. The advent of adenovirus: gene therapy for cardiovascular disease. Circulation. 1993;88:1937-1942.
4. Lemarchand P, Jones M. Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 1993;72:1132-1138.
5. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73:797-807.
6. Steg PG, Feldman LJ, Scoazec J-Y, Tahlil O, Barry JJ, Boulechfar S, Ragot T, Isner JM, Pericaudet M. Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation. 1994;90:1648-1656.
7. Rios CD, Ooboshi H, Piegors D, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer to normal and atherosclerotic arteries: a novel approach. Arterioscler Thromb Vasc Biol. 1995;15:2241-2245.
8. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res. 1995;77:7-13.
9. Chen AFY, Jiang S-W, Crotty TB, Tsutsui M, Smith L, O'Brien T, Katusic ZS. Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci U S A. 1997;94:12568-12573.
10. Yang Y, Qin S, Wilson, JM. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol. 1996;70:7209-7212.
11. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 1996; 2:545-550.
12. Davidson BL, Doran SE, Shewach DS, Latta JM, Hartman JW, Roessler BJ. Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Macaca mulatto following adenoviral-mediated gene transfer. Exp Neurol. 1994;125:258-267.
13. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 1993;3:219-223.
14. Willard JE, Landau C, Glamann B, Burns D, Jessen ME, Pirwitz MJ, Gerard RD, Meidell RS. Genetic modification of the vessel wall: comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation. 1994;89:2190-2197.
15. French BA, Maqur W, Ali NM, Geske RS, Finnigan JP, Rodgers GP, Roberts R, Raizner AE. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation. 1994;90:2402-2413.
16. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 1994;265:781-784.
17. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD. Gene transfer Io cerebral blood vessels after subarachnoid hemorrhage. Stroke. 1997;28:822-829.
18. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Henninghausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A. 1994;91:9302-9306.
19. Suzuki M, Singh RN, Crystal RG. Regulatable promoters for use in gene therapy applications: modification of the 5′ flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP. Hum Gene Ther. 1996;7:1883-1893.
20. Clesham GJ, Browne H, Efstathiou S, Weissberg PL. Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells. Circ Res. 1996;79: 1188-1195.
21. Thomsen DR, Stenberg RM, Goins WF, Stinski MF. Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci USA. 1984;81:659-663.
22. Stinski MF, Roehr TJ. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J Virol. 1985;55:431-441.
23. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 1985;41:521-530.
24. Hunninghake GW, Monick MM, Liu B, Stinski MF. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol. 1989;63:3026-3033.
25. Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Kay MA. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 1995;2: 151-155.
26. Gill TJ. The use of randomly bred and genetically defined animals in biomedical research. Am J Pathol. 1980;101:S21-S32.
27. Byrnes AP, Wood MJA, Charlton HM. Role of T cell in inflammation caused by adenovirus vectors in the brain. Gene Ther. 1996;3:644-651.
28. Kajiwara K, Byrnes AP, Charlton HM, Wood MJA, Wood KJ. Immune responses to adenoviral vectors during gene transfer in the brain. Hum Gene Ther. 1997;8:253-265.
29. Zinkernagel RM, Cooper S, Chambers J, Lazzarini RA, Hengartner H, Arnheiter H. Virus-induced autoantibody response to a transgenic viral antigen. Nature. 1990;345:68-71.
30. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1994;1:433-442.
31. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995;69:2004-2015.
32. Dai Y, Schwartz EM, Gu D, Zhang WW, Sarvetnick H, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A. 1995;92: 1401-1405.
33. Ooboshi H, Chu Y, Rios CD, Faraci FM, Davidson BL, Heistad DD. Altered vascular function following adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am J Physiol. 1997;42: H265-H270.
34. Shesely EG, Maeda N, Kim H-S, Kaushik MD, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1996;93:13176-13181.
35. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res. 1992;70: 248-256.
36. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke. 1993;24:392-399.
37. Faraci FM, Brian JE Jr. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
38. Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke. 1996;27:1688-1693.